Nuclear Medicine: Page 30

IBA, SCK CEN sign actinium-225 deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

AI can detect metastatic bone lesions on scintigraphy

By Erik L. Ridley

An artificial intelligence (AI) algorithm can identify and characterize suspicious bone lesions on whole-body bone scintigraphy exams in cancer patients, according to research published online September 4 in BMC Medical Imaging.

September 12, 2021

PET identifies early responders to liver cancer treatment

By Will Morton

PET imaging can predict how liver cancer patients are going to respond early after transarterial radioembolization, according to a study published online September 8 in the American Journal of Roentgenology.

September 9, 2021

NorthStar, Point Biopharma ink Ac-225 supply deal

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and Point Biopharma Global have signed a supply agreement covering the development and commercialization of the medical radioisotope actinium-225 (Ac-225).

September 7, 2021

Telix, Kettering to research PSMA radiotracer

By AuntMinnie.com staff writers

Kettering Health and Telix Pharmaceuticals have signed a deal to study Telix's investigational prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical, illuccix.

September 7, 2021

Hermes, Isotopia sign deal on dosimetry

By AuntMinnie.com staff writers

Nuclear medicine software developer Hermes Medical Solutions has signed a collaboration with Isotopia Molecular Imaging to support clinical studies to demonstrate the positive effects of personalized dosimetry and modulated radiopharmaceutical therapy on patient outcomes.

September 6, 2021

PET reveals triple threat behind Alzheimer's dementia

By Will Morton

PET imaging has shown for the first time how a triple threat of brain activity drives dementia in Alzheimer's disease patients -- and researchers created a visual map that lights up the culprit in action. Study details were published August 26 in Nature Medicine.

August 30, 2021

NorthStar wins $37M DOE award for Mo-99 production

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) Nuclear Security Administration has bestowed a $37 million award to NorthStar Medical Radioisotopes for the production of molybdenum-99 (Mo-99).

August 29, 2021

Iotron, CIIC to produce radioisotope Cu-67

By AuntMinnie.com staff writers

Iotron Medical and Canadian Isotope Innovations (CIIC) will produce the radioisotope copper-67 (Cu-67) for new cancer therapies.

August 24, 2021

Telix works with Merck on cancer therapies

By AuntMinnie.com staff writers

Telix Pharmaceuticals is entering into a collaboration with Merck for research studies on the combination of Merck's DNA damage response inhibitor molecules with Telix's therapeutic radiotracers.

August 19, 2021

New SPECT tracer detects aggressive breast cancer

By Will Morton

A new SPECT tracer based on technetium-99m is safe in patients and can detect metastatic breast cancer -- in a few cases, better than biopsies can, according to a study published August 12 in the Journal of Nuclear Medicine.

August 15, 2021

PET recommended over bone scintigraphy in pediatric sarcoma

By Will Morton

PET imaging is more effective than bone scintigraphy for detecting metastatic disease in children with soft-tissue cancer, according to a study published online August 9 in the European Journal of Cancer.

August 12, 2021

Previous Page

Page 30 of 438

Next Page